Friday, July 31, 2026

Celltrion’s Truxima becomes first rituximab biosimilar in U.S. to receive interchangeability designation

Celltrion's Truxima gains FDA interchangeability status, enhancing its market position and credibility in blood cancer treatment.

Tiger Research Forecasts U.S. Clarity Act Could Win Final Passage by July

The U.S. Clarity Act aims for passage by July, regulating stablecoins and enabling legal token issuance, boosting the digital asset market.

South Korea Preps for a U.S. 15% Global Tariff: Can Existing Agreements Keep the Fallout Limited?

South Korea's Finance Minister addresses the impact of U.S. global tariffs, stressing the need for proactive measures and existing agreements.

Tag: DAPA

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.